Nao Fujimori Selected Research

Nao Fujimori Research Topics

Disease

8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 09/2006
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021 - 11/2014
5	Neoplasms (Cancer) 02/2021 - 06/2008
5	Pancreatitis 01/2019 - 10/2011
4	Primitive Neuroectodermal Tumors (PNET) 01/2019 - 07/2012
3	Autoimmune Pancreatitis 03/2019 - 01/2012
3	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 08/2010
3	Fibrosis (Cirrhosis) 05/2014 - 01/2005
3	Chronic Pancreatitis 05/2014 - 01/2005
3	Inflammation (Inflammations) 01/2013 - 01/2005
2	Pathologic Constriction (Stenosis) 01/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 02/2021 - 12/2015
2	Hemorrhage 01/2021 - 12/2020
2	Immunoglobulin G4-Related Disease 01/2013 - 05/2012
1	Gastric Outlet Obstruction 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2021
1	False Aneurysm (Pseudoaneurysm) 01/2021
1	Rupture 01/2021
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2021
1	Necrosis 01/2020
1	Ulcer 01/2020
1	Ketosis 01/2019
1	Hyperglycemia 01/2019
1	Abdominal Pain (Pain, Abdominal) 01/2019
1	Neoplasms, Cystic, Mucinous, and Serous 07/2018
1	Insulinoma 01/2017
1	Neutropenia 10/2015
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2015
1	Chronic Hepatitis C 03/2015
1	Infections 03/2015
1	Iron Overload 03/2015
1	Pancreatic Pseudocyst 03/2013
1	Retroperitoneal Fibrosis 01/2013
1	Sialadenitis 05/2012
1	Ascites 09/2011
1	Disease Progression 09/2011
1	Anorexia 06/2008
1	Fatigue 06/2008
1	Nausea 06/2008

Drug/Important Bio-Agent (IBA)

5	Gemcitabine FDA Link 05/2019 - 09/2006
3	CytokinesIBA 02/2021 - 01/2005
3	Insulin (Novolin)FDA Link 01/2017 - 08/2010
2	lanreotide (Somatuline)FDA Link 11/2021 - 10/2021
2	Immunoglobulins (Immunoglobulin)IBA 03/2019 - 01/2013
2	Amylases FDA Link 01/2019 - 01/2018
2	Glucagon (Glukagon)FDA Link 01/2019 - 01/2017
2	dibutyldichlorotinIBA 05/2014 - 01/2005
2	Immunoglobulin G (IgG)IBA 01/2013 - 05/2012
2	SteroidsIBA 01/2013 - 05/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 08/2011
1	Everolimus FDA Link 11/2021
1	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 02/2021
1	folfirinoxIBA 12/2020
1	OMS 2017IBA 06/2020
1	MetalsIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 05/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	C-PeptideIBA 01/2019
1	C-Type Lectins (C-Type Lectin)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	EnzymesIBA 01/2018
1	Sunitinib (Sutent)FDA Link 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2015
1	IronIBA 03/2015
1	Antiviral Agents (Antivirals)IBA 03/2015
1	Chromogranin AIBA 11/2014
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2014
1	ONO 1301IBA 05/2014
1	ChemokinesIBA 01/2013
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2012
1	SecretagoguesIBA 07/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	NF-kappa B (NF-kB)IBA 01/2012
1	Interferon Regulatory FactorsIBA 01/2012
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 10/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2011
1	Bacterial DNAIBA 08/2011
1	Toll-Like Receptor 9IBA 08/2011
1	Tumor Biomarkers (Tumor Markers)IBA 06/2008
1	camostatIBA 01/2005
1	ProcollagenIBA 01/2005
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2005
1	Messenger RNA (mRNA)IBA 01/2005

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2022 - 09/2006
6	Therapeutics 12/2015 - 09/2006
5	Stents 01/2022 - 03/2013
2	Neoadjuvant Therapy 01/2022 - 05/2019
2	Pancreaticoduodenectomy 02/2021 - 01/2021
2	Self Expandable Metallic Stents 01/2021 - 01/2021
2	Pancreatectomy 07/2018 - 01/2010
1	Blood Transfusion (Blood Transfusions) 12/2020
1	Salvage Therapy 09/2011
1	Combination Drug Therapy (Combination Chemotherapy) 06/2008
1	Oral Administration 01/2005